Autoantibodies to calcium channels in type 1 diabetes mediate autonomic dysfunction by different mechanisms in colon and bladder and are neutralized by antiidiotypic antibodies

Journal of Autoimmunity

Volumn 31, Issue 1, 2008, Pages 66-72

  Wan, En Chi ^a   Gordon, Tom P ^a   Jackson, Michael W ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Autoantibodies; Autonomia; IVIg; Type 1 diabetes; Voltage gated calcium channels

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; AUTOANTIBODY; CALCIUM CHANNEL; IMMUNOGLOBULIN F(AB) FRAGMENT; SEPHAROSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; AUTONOMIC DYSFUNCTION; BLADDER DYSFUNCTION; COLON MOTILITY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NONHUMAN; OVERACTIVE BLADDER; PASSIVE TRANSPORT; PRIORITY JOURNAL; URODYNAMICS;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; AUTOANTIBODIES; CALCIUM CHANNELS, L-TYPE; COLON; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MICE; MICE, INBRED BALB C; MUSCLE CONTRACTION; MYOELECTRIC COMPLEX, MIGRATING; ORGAN SPECIFICITY; URINARY BLADDER;

EID: 43649085190     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2008.03.004     Document Type: Article

References (29)

1. Kelemen K. The role of T cells in beta cell damage in NOD mice and humans. Adv Exp Med Biol 552 (2004) 117-128
2. Vinik A.I., Park T.S., Stansberry K.B., and Pittenger G.L. Diabetic neuropathies. Diabetologia 43 (2000) 957-973
3. Vinik A.I., Maser R.E., Mitchell B.D., and Freeman R. Diabetic autonomic neuropathy. Diabetes Care 26 (2003) 1553-1579
4. Kaplan S.A., Te A.E., and Blaivas J.G. Urodynamic findings in patients with diabetic cystopathy. J Urol 153 (1995) 342-344
5. Jackson M.W. Gordon TP Waterman SA Disruption of intestinal motility by a calcium channel-stimulating autoantibody in type 1 diabetes. Gastroenterology 126 (2004) 819-828
6. Wan E.C. Gordon TP Jackson MW Autoantibody-mediated bladder dysfunction in type 1 diabetes. Scand J Immunol 65 (2007) 70-75
7. Drachman D.B. Autonomic "myasthenia": the case for an autoimmune pathogenesis. J Clin Invest 111 (2003) 797-799
8. Romi F., Kristoffersen E.K., Aarli J.A., and Gilhus N.E. The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo. J Neuroimmunol 158 (2005) 191-194
9. Lindstrom J. Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome. Annu Rev Immunol 3 (1985) 109-131
10. Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol 2 (2002) 797-804
11. Engel A.G., Lambert E.H., and Howard F.M. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin Proc 52 (1977) 267-280
12. Drachman D.B., Angus C.W., Adams R.N., Michelson J.D., and Hoffman G.J. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N Engl J Med 298 (1978) 1116-1122
13. Ephrem A., Misra N., Hassan G., Dasqupta S., Deliqnat S., Van Huyen J.P., et al. Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin. Clin Exp Med 5 (2005) 135-140
14. Buchwald B., Ahangari R., Weishaupt A., and Toyka K.V. Intravenous immunoglobulins neutralize blocking antibodies in Guillian-Barré syndrome. Ann Neurol 51 (2002) 673-680
15. Cavill D., Waterman S.A., and Gordon T.P. Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission. Arthritis Rheum 48 (2003) 3597-3602
16. Steinbuch M., and Audran R. The isolation of IgG from mammalian sera with the aid of caprylic acid. Arch Biochem Biophys 134 (1969) 279-284
17. Sapir T., and Shoenfeld Y. Facing the enigma of immunomodulatory effects of intravenous immunoglobulin. Clin Rev Allergy Immunol 29 (2005) 185-199
18. Pedersen K., Pandolfo M., and Mavroudakis N. Chronic inflammatory demyelinating polyneuropathy in a diabetic patient: deterioration after intravenous immunoglobulins treatment and favorable response to steroid treatment. Acta Neurol Belg 107 (2007) 14-17
19. Wang F., Jackson M.W., Maughan V., Cavill D., Smith A.J., Waterman S.A., et al. Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder. Arthritis Rheum 50 (2004) 3637-3645
20. Waterman S.A. Lang B Newsom-Davis J Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse. Ann Neurol 42 (1997) 147-156
21. Meier M., Linke R., Tatsch K., Standl E., and Schnell O. An advanced approach for the assessment of gastric motor function in long-term type 1 diabetes mellitus with and without autonomic neuropathy. Clin Auton Res 12 (2002) 197-202
22. Rosztoczy A., Roka R., Varkonyi T.T., Lengyel C., Izbeki F., Lonovics J., et al. Regional differences in the manifestation of gastrointestinal motor disorders in type 1 diabetic patients with autonomic neuropathy. Z Gastroenterol 42 (2004) 1295-1300
23. Samsom M., Jebbink R.J., Akkermans L.M., van Berge-Henegouwen G.P., and Smout A.J. Abnormalities of antroduodenal motility in type I diabetes. Diabetes Care 19 (1996) 21-27
24. Ebert E.C. Gastrointestinal complications of diabetes mellitus. Dis Mon 51 (2005) 620-663
25. Colagiuri S., Leong G.M., Thayer Z., Antony G., Dwyer J.M., Kidson W., et al. Intravenous immunoglobulin therapy for autoimmune diabetes mellitus. Clin Exp Rheumatol 15 Suppl. 14 (1996) S93-S97
26. Schnell O., Eisfelder B., Standl E., and Ziegler A.G. High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM. Diabetes 46 (1997) 1607-1611
27. Smith A.J., Jackson M.W., Wang F., Cavill D., Rischmueller M., and Gordon T.P. Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjogren syndrome. Hum Immunol 66 (2005) 411-416
28. Kazatchkine M.D., Dietrich G., Hurez V., Ronda N., Bellon B., Rossi F., et al. V region-mediated selection of autoreactive repertoires by intravenous immunoglobulin (i.v.Ig). Immunol Rev 139 (1994) 79-107
29. Bayry J., Misra N., Latry V., Prost F., Delignat S., Lacroix-Desmazes S., et al. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Transfus Clin Biol 10 (2003) 165-169